GABA Signal Blocking Boosts Glioblastoma Survival in Female Models

Researchers have identified a critical biological difference in how glioblastoma develops in male and female laboratory models, pinpointing an immune pathway that fuels tumor growth only in females. The study shows that the neurotransmitter GABA boosts the cancer-protecting activity of immune cells in female models—but not male models—and that blocking that signal improved outcomes. The findings could one day lead to new drug targets and therapeutics specifically for women. The paper is published in the journal Nature Cancer.